Navigation Links
Dr. Jill's Foot Pads Secures GSA Schedule and Expands to Service VA and Federal Agencies

DEERFIELD BEACH, Fla., July 9, 2012 /PRNewswire/ -- GSA Applications is pleased to announce that Dr. Jill's Foot Pads, Inc. has been awarded a GSA Schedule 65 IIA contract and is now certified to provide Foot Pads and Padding supplies to all agencies of the federal government.  Dr. Jill's Foot Pads has placed their extensive Foot Pad inventory of Felts, Foams, Moleskin, Gels, insoles and more on the government's electronic ordering system, GSA Advantage!®.

"This schedule opens up significantly more markets for us throughout the country including VA Hospitals, military service branches Indian Health Services and more," states Jay Scheur, VP Operations. Adding, "With our GSA schedule, any branch of the federal government can take advantage of our approved government pricing and purchase from a fully vetted US manufacturer."

Their products are designed in-house and reflect the staff's 100-year combined experience. As designers and manufacturers, they have been able to customize products to meet the divergent needs of their clients. They feature a website dedicated to Medical Professionals and an Online Store, enabling the public to purchase the same quality products sold to medical professionals.

Dr. Jill Scheur worked within the VA Medical system from 1993 through 1998. Her hands on experience uncovered a true need for an affordable, domestically produced Foot Pad line. Dr. Jill's Foot Pads was established in 2001 and has long outgrown their original facility. Currently operating from their expansive manufacturing facility, they produce an extensive variety of felt, foam, moleskin, gel, and padding supplies.  Dr. Jill's Foot Pads is the only company in the USA that specializes in this product line and goes directly to the medical professionals with 99% of their products proudly "Made in the USA." Of the numerous items developed in-house, the most exciting is their  re-useable line of Purple Gel Pads which feature a non-adhesive, self-sticking, washable pad, that are also Latex Free. These are available in Ball-of-Foot Pads; U-Shaped Callus Pads; Dancers Pads; Arch Pads; and numerous other configurations as required by users.

About Dr. Jill's Foot Pads Inc.: Founded by Podiatrist Dr. Jill Scheur in 2001, Dr. Jill's Foot Pads is a registered Woman Owned Small Business operated by Jill and her husband Jay. Their products are manufactured domestically and service over 9,000 Podiatrists, Chiropodists, Pedorthists, Orthopedists, Orthotic Labs, DME's and Chiropractors throughout the USA. Dr. Jill's Foot Pads also supply the majority of NFL teams, other PRO teams, numerous college sports programs and Athletic Trainers worldwide. Their commitment to customer service is clearly demonstrated with a standing goal to ship orders the same day received. Visit for more information.

CONTACTS: Dr. Jill's Foot Pads: Jay Scheur, VP Operations 866-366-8723


SOURCE Dr. Jill’s Foot Pads Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Delcath Systems, Inc. Secures $20 Million Credit Facility
2. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
3. Benvenue Medical Secures $25 Million Series D Financing
4. PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital
5. Thoratec Schedules First Quarter Conference Call, Webcast
6. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
7. Heartware Schedules First Quarter Conference Call And Webcast
8. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
9. Ampio Pharmaceuticals Schedules 2012 Update Webcast
10. Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online
11. China Botanic Schedules Conference Call to Discuss Second Quarter Fiscal Year 2012 Results
Post Your Comments:
(Date:10/13/2015)... VEGAS , Oct. 13, 2015 VIVA ... of vascular medicine and intervention through education and research, ... annual conference,  VIVA 2015 . Sixteen trial results, featuring ... released for the first time on Monday and Tuesday, ... --> --> Since ...
(Date:10/13/2015)... , Oct. 13, 2015  Kay Elledge, ... and Fellow American College of Obstetrics and Gynecology ... evolve by establishing the Genuine Self Medical Laser ... and men.  In recognition of Breast Cancer ... special promotion for MonaLisa Touch treatments ...
(Date:10/13/2015)... PITTSBURGH , Oct. 13, 2015  Mylan N.V. (Nasdaq: ... at 5:00 p.m. ET host a conference call and webcast ... Company plc (NYSE: PRGO ; TASE) shareholders through Mylan,s ... by Mylan,s Executive Chairman Robert J. Coury , CEO ... --> --> Mylan ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... October 13, 2015 , ... ... of Excellence in the Life Sciences Initiative aimed at enhancing Purdue’s life sciences ... $2 billion “Ever True” capital campaign. , The investment will result in cohesive ...
(Date:10/13/2015)... West Palm Beach, FL (PRWEB) , ... October 13, 2015 , ... ... acquisition of Global Laser Vision of San Diego, California. With brands including The LASIK ... 3.3 million successful procedures, making it the nationwide leader in laser vision correction. , ...
(Date:10/13/2015)... N.J. (PRWEB) , ... October 13, 2015 , ... ... media enterprise focused on cancer patients, today announced a new partnership with the ... patients battling this rare type of non-Hodgkin’s lymphoma, their families and physicians. ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... beverage companies in the United States, today announced the release of its limited ... and new Cranberry Cocktail Agua Fresca. All feature the unique flavor combinations and ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... technology platform, ENGAGE, at HIMSS’s Patient Engagement Summit . HealthAware is a ... delivers innovative health programs and interventions via mobile devices that provide a framework ...
Breaking Medicine News(10 mins):